Effects of Coronavirus Disease Pandemic on Tuberculosis Notifications, Malawi
Rebecca Nzawa Soko1
, Rachael M. Burke1
, Helena R.A. Feasey, Wakumanya Sibande, Marriott Nliwasa, Marc Y.R. Henrion, McEwen Khundi, Peter J. Dodd, Chu Chang Ku, Gift Kawalazira, Augustine T. Choko, Titus H. Divala, Elizabeth L. Corbett2
, and Peter MacPherson2
Author affiliations: Malawi Liverpool Wellcome Clinical Research Programme, Blantyre, Malawi (R. Nzawa Soko, R.M. Burke, H.R.A. Feasey, W. Sibande, M. Nliwasa, M.Y.R. Henrion, M. Khundi, A.T. Choko, T.H. Divala, E.L. Corbett, P. MacPherson); London School of Hygiene and Tropical Medicine, London, UK (R. Nzawa Soko, R.M. Burke, H.R.A. Feasey, M. Khundi, T.H. Divala, E.L. Corbett, P. MacPherson); University of Malawi College of Medicine, Blantyre (M. Nliwasa); Liverpool School of Tropical Medicine, Liverpool, UK (M.Y.R. Henrion, P. MacPherson); University of Sheffield, Sheffield, UK (P.J. Dodd, C.C. Ku); District Health Office, Blantyre (G. Kawalazira)
Figure 1. Effects of coronavirus disease (COVID-19) pandemic on monthly TB case notification rates in Blantyre, Malawi. Circles represent the observed number of cases each month. Solid blue line represents the fitted model with both step and slope change due to COVID-19; teal shaded area represents 95% CI. Pink dotted line represents counterfactual expected TB rates; pink shaded area represents 95% CI. Gray shaded area on the right indicates timeframe in which the COVID-19 emergency was declared in Malawi. TB, tuberculosis.
Page created: May 04, 2021
Page updated: June 16, 2021
Page reviewed: June 16, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.